Julia Hepp

419 total citations
8 papers, 225 citations indexed

About

Julia Hepp is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Julia Hepp has authored 8 papers receiving a total of 225 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Immunology. Recurrent topics in Julia Hepp's work include Peptidase Inhibition and Analysis (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Ubiquitin and proteasome pathways (2 papers). Julia Hepp is often cited by papers focused on Peptidase Inhibition and Analysis (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Ubiquitin and proteasome pathways (2 papers). Julia Hepp collaborates with scholars based in Germany, Netherlands and United States. Julia Hepp's co-authors include David M. Brown, Brian B. Berger, Jeffrey S. Heier, Roomasa Channa, Ulrike Fiedler, Michael T. Stumpp, Peter A. Campochiaro, M.M. Helsen, Wim B. van den Berg and Patrick A. Baeuerle and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of the Rheumatic Diseases.

In The Last Decade

Julia Hepp

7 papers receiving 210 citations

Peers

Julia Hepp
Anna M. Marzeda United Kingdom
Ikram El Zaoui Switzerland
Esin Kotiloğlu Karaa United Kingdom
Anna M. Marzeda United Kingdom
Julia Hepp
Citations per year, relative to Julia Hepp Julia Hepp (= 1×) peers Anna M. Marzeda

Countries citing papers authored by Julia Hepp

Since Specialization
Citations

This map shows the geographic impact of Julia Hepp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Hepp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Hepp more than expected).

Fields of papers citing papers by Julia Hepp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Hepp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Hepp. The network helps show where Julia Hepp may publish in the future.

Co-authorship network of co-authors of Julia Hepp

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Hepp. A scholar is included among the top collaborators of Julia Hepp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Hepp. Julia Hepp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kreimendahl, Franziska, Yvonne Marquardt, Christian Apel, et al.. (2019). Macrophages significantly enhance wound healing in a vascularized skin model. Journal of Biomedical Materials Research Part A. 107(6). 1340–1350. 35 indexed citations
2.
Hepp, Julia, Christian Reichen, Alexander Titz, et al.. (2018). Abstract 3752: Preclinical pharmacology of MP0310: A 4-1BB/FAP bispecific DARPin drug candidate promoting tumor-restricted T-cell costimulation. Cancer Research. 78(13_Supplement). 3752–3752. 3 indexed citations
3.
Reichen, Christian, Stefan Imobersteg, Martin Béhé, et al.. (2018). Abstract 3029: FAP-mediated tumor accumulation of a T-cell agonistic FAP/4-1BB DARPin drug candidate analyzed by SPECT/CT and quantitative biodistribution. Cancer Research. 78(13_Supplement). 3029–3029. 3 indexed citations
4.
Fiedler, Ulrike, Christian Reichen, Anja Schlegel, et al.. (2018). Abstract 4552: Tumor-restricted immune modulation by multispecific molecules from the DARPin toolbox. Cancer Research. 78(13_Supplement). 4552–4552. 1 indexed citations
5.
Hepp, Julia, Ulrike Fiedler, Christian Reichen, et al.. (2017). Comparison of an FAP-targeted, CD137 activating DARPin drug candidate with a non-targeted, CD137 activating antibody in a human PBMC transplanted HT-29 mouse tumor model.. Journal of Clinical Oncology. 35(15_suppl). e14626–e14626. 1 indexed citations
6.
Campochiaro, Peter A., Roomasa Channa, Brian B. Berger, et al.. (2012). Treatment of Diabetic Macular Edema With a Designed Ankyrin Repeat Protein That Binds Vascular Endothelial Growth Factor: A Phase I/II Study. American Journal of Ophthalmology. 155(4). 697–704.e2. 87 indexed citations
7.
Hagn, Magdalena, Kai Sontheimer, Oleg Lunov, et al.. (2010). CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B. European Journal of Immunology. 40(7). 2060–2069. 54 indexed citations
8.
Plater-Zyberk, C, Leo A. B. Joosten, M.M. Helsen, et al.. (2006). GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice. Annals of the Rheumatic Diseases. 66(4). 452–457. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026